US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

AdvisorShares Psychedelics ETF

26.40

-0.4000-1.49%

Volume:20.10K

Turnover:532.69K

Market Cap:59.27M

PE:- -

High:27.02

Open:26.43

Low:26.29

Close:26.80

52wk High:27.02

52wk Low:15.63

Shares:2.24M

Float Shares:2.24M

Volume Ratio:0.46

T/O Rate:0.90%

Dividend:1.70

Dividend Rate:6.46%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Alkermes - Alixorexton Shows Sustained Improvement on Mwt and ESS at Week 24, Nine Months After First Dose

THOMSON REUTERS

Alkermes’ Alixorexton Demonstrated Sustained Improvement in Wakefulness in Adults with Narcolepsy Type 1 and Type 2 in Long-term Extension Study Interim Analysis

THOMSON REUTERS

Bank of America Securities Remains a Sell on Alkermes (ALKS)

Alkermes Plc : JP Morgan Resumes Coverage with Neutral Rating; Target Price $60

THOMSON REUTERS

Noronex plans substantial multi-instrument equity raising

Sabre Resources Secures $2m to Accelerate Drilling in Tennant Creek Copper-Gold Belt

Analysts Are Bullish on These Healthcare Stocks: Immunome (IMNM), COMPASS Pathways (CMPS)

Wells Fargo, BKR, SLB, HAL, CMPS Trending With Analysts

Mizuho Securities Remains a Buy on Relmada Therapeutics (RLMD)

European Equities Traded in the US as American Depositary Receipts Rise Thursday

MT Newswires Live

Analysts Offer Insights on Healthcare Companies: Alkermes (ALKS) and Immunome (IMNM)

Renerve Plans Issue of 1.6 Million Unlisted Convertible Notes

Analysts Offer Insights on Healthcare Companies: Schrodinger (SDGR), Amphastar Pharmaceuticals (AMPH) and COMPASS Pathways (CMPS)

Analysts Have Conflicting Sentiments on These Healthcare Companies: Evolus (EOLS), Alkermes (ALKS) and VolitionRX (VNRX)

Compass Pathways' COMP360 Data Supports FDA Approval Potential, RBC Says

MT Newswires Live

Evercore upgrades Compass Pathways to Outperform, views approval as likely

Alkermes - no Penalties or Further Obligations Owed by Alkermes or Amneal After Agreement Termination - SEC Filing

THOMSON REUTERS

Alkermes - Co and Amneal Terminate Authorized Generic Product Supply Agreement on July 6, 2026 - SEC Filing

THOMSON REUTERS

Why COMPASS Pathways (CMPS) Is Down 8.2% After New Phase 3 Data and Rolling NDA Update

Simply Wall St.

Analyst Reaffirms Buy on CMPS, Viewing Post-Data Pullback as Entry Opportunity Ahead of 1H27 Launch

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/PSIL/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PSIL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PSIL\",,,,,undefined,":{"symbol":"PSIL","market":"US","secType":"STK","nameCN":"AdvisorShares Psychedelics ETF","latestPrice":26.4,"timestamp":1787770084418,"preClose":26.8,"halted":0,"volume":20103,"delay":0,"changeRate":-0.014925373134328438,"floatShares":2244976,"shares":2244976,"eps":0,"marketStatus":"Trading","change":-0.4,"latestTime":"08-26 14:49:49 EDT","open":26.429,"high":27.0175,"low":26.29,"amount":532689.816678,"amplitude":0.027146,"askPrice":26.6,"askSize":1000,"bidPrice":26.09,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1787774400000},"marketStatusCode":2,"adr":0,"exchange":"ARCA","adjPreClose":26.8,"sharesOutstanding":1184976,"nav":25.732,"aum":57766911.89,"dividendRate":0.06458,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":26.9,"preClose":26.8,"latestTime":"08:45 EDT","volume":844,"amount":22607.829632,"timestamp":1787748339359,"change":0.1,"changeRate":0.003731,"amplitude":0.033955},"postHourTrading":{"tag":"盘后","latestPrice":26.88,"preClose":26.8,"latestTime":"19:32 EDT","volume":216,"amount":5804.83,"timestamp":1787700759051,"change":0.08,"changeRate":0.002985,"amplitude":0.002985},"volumeRatio":0.463946,"impliedVol":0.458,"impliedVolPercentile":0.8486},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PSIL\",,,,,undefined,":{"symbol":"PSIL","floatShares":2244976,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.463946,"shares":2244976,"dividePrice":1.7049,"high":27.0175,"amplitude":0.027146,"preClose":26.8,"low":26.29,"week52Low":15.6348,"pbRate":"--","week52High":27.0175,"institutionHeld":0,"latestPrice":26.4,"committee":-0.818182,"eps":0,"divideRate":0.06458,"volume":20103,"delay":0,"ttmEps":0,"open":26.429,"prevYearClose":17.17,"prevWeekClose":25.86,"prevMonthClose":23.5,"prevQuarterClose":24.05,"fiveDayClose":26.24,"twentyDayClose":23.23,"sixtyDayClose":21.94},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PSIL\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"PSIL","amount":1.68387,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-29","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-29"},{"date":"2025-09-22","symbol":"PSIL","amount":0.02007,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-29","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-29"},{"date":"2025-06-23","symbol":"PSIL","amount":0.01191,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"},{"date":"2025-03-21","symbol":"PSIL","amount":0.16343,"announcedDate":"2025-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-21","defaultRemindTime":1742563800000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-28","payableDate":"2025-03-21","currency":"USD","dateTimestamp":1742529600000,"payDate":"2025-03-28"},{"date":"2024-12-23","symbol":"PSIL","amount":0.05477,"announcedDate":"2024-12-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-30","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-30"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PSIL\",market:\"US\",,,undefined,":[{"executeDate":"2022-09-26","recordDate":"2022-09-27","paymentDate":"2022-09-30","value":0.05421,"currency":"USD"},{"executeDate":"2023-09-25","recordDate":"2023-09-26","paymentDate":"2023-09-29","value":0.00336,"currency":"USD"},{"executeDate":"2024-09-23","recordDate":"2024-09-23","paymentDate":"2024-09-30","value":0.1087,"currency":"USD"},{"executeDate":"2024-12-23","recordDate":"2024-12-23","paymentDate":"2024-12-30","value":0.05477,"currency":"USD"},{"executeDate":"2025-03-21","recordDate":"2025-03-21","paymentDate":"2025-03-28","value":0.16343,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PSIL\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PSIL\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2651115976","title":"Alkermes - Alixorexton Shows Sustained Improvement on Mwt and ESS at Week 24, Nine Months After First Dose","url":"https://stock-news.laohu8.com/highlight/detail?id=2651115976","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651115976?lang=en_us&edition=fundamental","pubTime":"2026-07-13 19:00","pubTimestamp":1783940428,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nFWN43D02G:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALKS","IBRN","FBT","BK4139","PSIL","PSCH","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651115189","title":"Alkermes’ Alixorexton Demonstrated Sustained Improvement in Wakefulness in Adults with Narcolepsy Type 1 and Type 2 in Long-term Extension Study Interim Analysis","url":"https://stock-news.laohu8.com/highlight/detail?id=2651115189","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651115189?lang=en_us&edition=fundamental","pubTime":"2026-07-13 19:00","pubTimestamp":1783940428,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nFWN43D02G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FBT","BK4139","MEDX","IBRN","PSIL","ALKS","PSCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651192046","title":"Bank of America Securities Remains a Sell on Alkermes (ALKS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2651192046","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651192046?lang=en_us&edition=fundamental","pubTime":"2026-07-13 16:45","pubTimestamp":1783932314,"startTime":"0","endTime":"0","summary":"In a report released on July 10, Jason Gerberry from Bank of America Securities maintained a Sell rating on Alkermes, with a price target of $38.00...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bank-of-america-securities-remains-a-sell-on-alkermes-alks-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bank-of-america-securities-remains-a-sell-on-alkermes-alks-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBRN","BK4559","BK4207","LU1894683348.USD","ALKS","IYG","LU0640476718.USD","KBWB","MEDX","LU0130518102.USD","IE00B19Z3581.USD","LU1363072403.SGD","IYF","FNCL","LU0208291251.USD","IE00BLSP4452.SGD","PSCH","LU0648001328.SGD","UYG","LU0306806265.USD","LU2265009873.SGD","LU2133065610.SGD","LU0203347892.USD","LU0130102774.USD","LU2129689514.USD","LU0980610538.SGD","PSIL","IE00BZ1G4Q59.USD","LU0211331839.USD","LU0234572021.USD","LU1201861249.SGD","LU1506573853.SGD","LU1894683264.USD","FTXO","LU0321505439.SGD","LU0320765489.SGD","LU1718418525.SGD","VFH","LU0648000940.SGD","LU0256863902.USD","LU0417517546.SGD","FBT","BK4581","LU0070302665.USD","LU0868494617.USD","LU0106831901.USD","LU0306807586.USD","PGF","XLF","BAC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651193713","title":"Alkermes Plc : JP Morgan Resumes Coverage with Neutral Rating; Target Price $60","url":"https://stock-news.laohu8.com/highlight/detail?id=2651193713","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651193713?lang=en_us&edition=fundamental","pubTime":"2026-07-13 13:58","pubTimestamp":1783922324,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nFWN43F04A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PSCH","MEDX","ALKS","BK4139","FBT","PSIL","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651162556","title":"Noronex plans substantial multi-instrument equity raising","url":"https://stock-news.laohu8.com/highlight/detail?id=2651162556","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651162556?lang=en_us&edition=fundamental","pubTime":"2026-07-13 09:27","pubTimestamp":1783906060,"startTime":"0","endTime":"0","summary":"Noronex Ltd. ( ($AU:NRX) ) has issued an update. Noronex Limited has outlined plans for a new capital raising, proposing the issue of up to 196,818...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/noronex-plans-substantial-multi-instrument-equity-raising?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/noronex-plans-substantial-multi-instrument-equity-raising?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651169019","title":"Sabre Resources Secures $2m to Accelerate Drilling in Tennant Creek Copper-Gold Belt","url":"https://stock-news.laohu8.com/highlight/detail?id=2651169019","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651169019?lang=en_us&edition=fundamental","pubTime":"2026-07-13 07:04","pubTimestamp":1783897464,"startTime":"0","endTime":"0","summary":"Sabre Resources Ltd ( ($AU:SBR) ) has shared an update. Sabre Resources has completed a A$2 million capital raising, including a second tranche of ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sabre-resources-secures-2m-to-accelerate-drilling-in-tennant-creek-copper-gold-belt?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sabre-resources-secures-2m-to-accelerate-drilling-in-tennant-creek-copper-gold-belt?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SABR","BK4142","BK4585","BK4588","SETM","AAQC","BK4106","DBB","BK4161","PICK","BK4535","TNC","COPX","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650159213","title":"Analysts Are Bullish on These Healthcare Stocks: Immunome (IMNM), COMPASS Pathways (CMPS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2650159213","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650159213?lang=en_us&edition=fundamental","pubTime":"2026-07-11 22:40","pubTimestamp":1783780807,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Immunome (IMNM) and COMPASS Pathways (CMPS) with bul...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-immunome-imnm-compass-pathways-cmps-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-immunome-imnm-compass-pathways-cmps-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL","CMPS","IMNM","BK4139","BK4563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650156370","title":"Wells Fargo, BKR, SLB, HAL, CMPS Trending With Analysts","url":"https://stock-news.laohu8.com/highlight/detail?id=2650156370","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650156370?lang=en_us&edition=fundamental","pubTime":"2026-07-11 17:01","pubTimestamp":1783760510,"startTime":"0","endTime":"0","summary":"Analysts are intrested in these 5 stocks: ( ($WFC) ), ( ($BKR) ), ( ($SLB) ), ( ($HAL) ) and ( ($CMPS) ). Here is a breakdown of their recent","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/weekend-updates/wells-fargo-bkr-slb-hal-cmps-trending-with-analysts?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/weekend-updates/wells-fargo-bkr-slb-hal-cmps-trending-with-analysts?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FTXO","IE00B0JY6N72.USD","PGF","PSIL","IE00B19Z3B42.SGD","LU0072461881.USD","LU0130102774.USD","LU0154245756.USD","LU0985489474.SGD","CMPS","HAL","BKR","LU1506573853.SGD","LU1201861249.SGD","LU1363072403.SGD","LU0011850046.USD","LU0477156953.USD","LU0070302665.USD","LU1261432733.SGD","LU0251142724.SGD","LU0648001328.SGD","LU0314106906.USD","PXJ","LU0267386448.USD","LU2361044949.HKD","IE0002270589.USD","LU0640476718.USD","LU0128525689.USD","LU1035773651.USD","LU0211327993.USD","SG9999011175.SGD","LU1074936037.SGD","LU0417517546.SGD","LU2461242641.AUD","LU1267930490.SGD","SGXZ23171101.USD","LU0251131958.USD","LU0310799852.SGD","SG9999003800.SGD","IEZ","SLB","LU1720051108.HKD","LU0985481810.HKD","LU1069347547.HKD","VDE","WFC","KBWB","IYF","OIH","DIG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650171187","title":"Mizuho Securities Remains a Buy on Relmada Therapeutics (RLMD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2650171187","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650171187?lang=en_us&edition=fundamental","pubTime":"2026-07-10 19:55","pubTimestamp":1783684550,"startTime":"0","endTime":"0","summary":"In a report released today, Uy Ear from Mizuho Securities maintained a Buy rating on Relmada Therapeutics, with a price target of $19.00. According...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/mizuho-securities-remains-a-buy-on-relmada-therapeutics-rlmd-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/mizuho-securities-remains-a-buy-on-relmada-therapeutics-rlmd-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4207","GSIB","RLMD","MFG","BK4007","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650780109","title":"European Equities Traded in the US as American Depositary Receipts Rise Thursday","url":"https://stock-news.laohu8.com/highlight/detail?id=2650780109","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650780109?lang=en_us&edition=fundamental","pubTime":"2026-07-09 23:10","pubTimestamp":1783609858,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were rising on Thursday morning, up 0.5% to 1,905.06 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by technology giants Nokia  and Ericsson , which gained 6% and 4.4% respectively. They were followed by semiconductor company STMicroelectronics , which climbed nearly 4%.The decliners from continental Europe were led by clinical-stage biopharmaceutical company Inventiva  and steel producer ArcelorMittal , which fell 4.3% and 1.5% respectively. They were followed by software company SAP , which shed 0.7%.From the UK and Ireland, the gainers were led by semiconductor company Arm  and bank HSBC , which climbed 12% and 2% respectively. They were followed by bank Barclays , which added 1.8%.The decliners from the UK and Ireland were led by pharmaceutical company Compass Pathways  and budget airline Ryanair , which decreased 2.2% and 1.5% respectively.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0128525689.USD","MT","BK4613","ARMW","BK4532","BK4547","LNOK","RYAAY","IE00BMPRXR70.SGD","BK4561","BK4604","BK4609","BK4585","SAP","BK4543","HSBH","LU0648000940.SGD","BK4605","BK4554","BK4528","BK4500","LU0976567544.SGD","NOK","BCS","LU0348723411.USD","PSIL","00005","IVA","LU2543165471.USD","ARMU","AIPI","LU0081259029.USD","SPRX","LU1201861165.SGD","IE00BMPRXQ63.HKD","CMPS","BK4515","LU0266013472.USD","BK4566","BK4521","ERIC","IE00BMPRXN33.USD","BK4141","LU0006061336.USD","LU0310800965.SGD","LU0496365809.HKD","QQQA","HSBC","LU1232071149.USD","ARMG","BK4008","BK4548","BK4591","LU0211326755.USD","LU0130103400.USD","STM","BK4020","LU0211326839.USD","ARM","LU2236285917.USD","LU0052756011.USD","BK4588","BK4207","BK4139","LU1267930227.SGD","BK4023","TRFK","BK4006"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650292217","title":"Analysts Offer Insights on Healthcare Companies: Alkermes (ALKS) and Immunome (IMNM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2650292217","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650292217?lang=en_us&edition=fundamental","pubTime":"2026-07-09 21:10","pubTimestamp":1783602606,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Alkermes (ALKS) and Immunome (IMNM) with bullish sen...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-alkermes-alks-and-immunome-imnm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-alkermes-alks-and-immunome-imnm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IMNM","BK4137","LABU","XBI","PSCH","XLV","BK4585","BK4563","HCSG","BK4139","ALKS","PSIL","LU0029874061.USD","BK4588","IBRN","MEDX","LU0128526141.USD","FBT","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650911057","title":"Renerve Plans Issue of 1.6 Million Unlisted Convertible Notes","url":"https://stock-news.laohu8.com/highlight/detail?id=2650911057","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650911057?lang=en_us&edition=fundamental","pubTime":"2026-07-09 07:28","pubTimestamp":1783553305,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Renerve Limited ( ($AU:RNV) ). Renerve Limited has announced a proposed capital raising through the issue of up...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/renerve-plans-issue-of-1-6-million-unlisted-convertible-notes?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/renerve-plans-issue-of-1-6-million-unlisted-convertible-notes?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650990836","title":"Analysts Offer Insights on Healthcare Companies: Schrodinger (SDGR), Amphastar Pharmaceuticals (AMPH) and COMPASS Pathways (CMPS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2650990836","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650990836?lang=en_us&edition=fundamental","pubTime":"2026-07-09 00:40","pubTimestamp":1783528810,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Schrodinger (SDGR), Amphastar Pharmaceuticals (AMPH) and COMPASS ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-schrodinger-sdgr-amphastar-pharmaceuticals-amph-and-compass-pathways-cmps-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-schrodinger-sdgr-amphastar-pharmaceuticals-amph-and-compass-pathways-cmps-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","CMPS","XBI","BK4585","PSIL","XLV","AMPH","BK4167","LU0029874061.USD","SDGR","BK4137","BK4581","BK4007","LU0128526141.USD","BK4139","BK4557","HCSG","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650997530","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Evolus (EOLS), Alkermes (ALKS) and VolitionRX (VNRX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2650997530","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650997530?lang=en_us&edition=fundamental","pubTime":"2026-07-08 23:50","pubTimestamp":1783525804,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Evolus (EOLS), Alkermes (ALKS) and VolitionRX (VNR...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-evolus-eols-alkermes-alks-and-volitionrx-vnrx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-evolus-eols-alkermes-alks-and-volitionrx-vnrx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4198","LU0128526141.USD","EOLS","MEDX","IBRN","PSIL","BK4007","BK4139","VNRX","LABU","BK4137","BK4581","XLV","HCSG","LU0029874061.USD","PSCH","FBT","BK4585","XBI","BK4588","ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649992244","title":"Compass Pathways' COMP360 Data Supports FDA Approval Potential, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2649992244","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649992244?lang=en_us&edition=fundamental","pubTime":"2026-07-08 23:36","pubTimestamp":1783524996,"startTime":"0","endTime":"0","summary":"Compass Pathways'  recent six-month trial data for COMP360 in treatment-resistant depression supports its potential for US Food and Drug Administration approval, a 2027 launch, and a more than $1.7 billion market opportunity, RBC Capital Markets said in a note Tuesday.The analysts said the data showed a meaningful dose-response, durability, and a more convenient dosing schedule than currently marketed alternatives.The treatment also continued to show a favorable safety profile, with most adverse events occurring only on the day of treatment, according to RBC.Given the strong clinical data, favorable regulatory designations, physician interest and patient demand, Compass Pathways is well positioned for future share price gains driven by its underlying business fundamentals, the analysts said.They added that COMP360's effectiveness is competitive with newer treatments such as Spravato and LSD-based therapies, offering durable benefits after one to three doses, \"and when accounting for di","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","LABU","PSIL","BK4585","BK4139","CMPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649999732","title":"Evercore upgrades Compass Pathways to Outperform, views approval as likely","url":"https://stock-news.laohu8.com/highlight/detail?id=2649999732","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649999732?lang=en_us&edition=fundamental","pubTime":"2026-07-08 21:40","pubTimestamp":1783518054,"startTime":"0","endTime":"0","summary":"As previously reported, Evercore ISI upgraded Compass Pathways (CMPS) to Outperform from In Line with a price target of $21, up from $8. The crux o...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/evercore-upgrades-compass-pathways-to-outperform-views-approval-as-likely-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/evercore-upgrades-compass-pathways-to-outperform-views-approval-as-likely-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL","CMPS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649993013","title":"Alkermes - no Penalties or Further Obligations Owed by Alkermes or Amneal After Agreement Termination - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2649993013","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649993013?lang=en_us&edition=fundamental","pubTime":"2026-07-08 20:05","pubTimestamp":1783512335,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260708:nFWN43A0A0:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IBRN","MEDX","PSIL","PSCH","FBT","BK4139","ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649017993","title":"Alkermes - Co and Amneal Terminate Authorized Generic Product Supply Agreement on July 6, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2649017993","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649017993?lang=en_us&edition=fundamental","pubTime":"2026-07-08 20:05","pubTimestamp":1783512335,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260708:nFWN43A0A0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","FBT","MEDX","PSIL","PSCH","IBRN","ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649995643","title":"Why COMPASS Pathways (CMPS) Is Down 8.2% After New Phase 3 Data and Rolling NDA Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2649995643","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649995643?lang=en_us&edition=fundamental","pubTime":"2026-07-08 07:32","pubTimestamp":1783467133,"startTime":"0","endTime":"0","summary":"Compass Pathways recently reported 26-week results from its second Phase 3 COMP006 trial of COMP360 for treatment-resistant depression, showing rapid and durable symptom improvement alongside a generally well-tolerated safety profile in nearly 600 participants with highly chronic illness.\nThe data suggest that a second 25 mg dose may enhance and extend clinical benefit for some patients, while the company advances a rolling New Drug Application with the FDA toward a potential US launch,...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cmps/compass-pathways/news/why-compass-pathways-cmps-is-down-82-after-new-phase-3-data","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cmps/compass-pathways/news/why-compass-pathways-cmps-is-down-82-after-new-phase-3-data","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["QTOC","PSIL","CMPS","AIPO","AGIX","VTHR","CHAT","BK4139","ARTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649937358","title":"Analyst Reaffirms Buy on CMPS, Viewing Post-Data Pullback as Entry Opportunity Ahead of 1H27 Launch","url":"https://stock-news.laohu8.com/highlight/detail?id=2649937358","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649937358?lang=en_us&edition=fundamental","pubTime":"2026-07-08 03:45","pubTimestamp":1783453527,"startTime":"0","endTime":"0","summary":"Wolfe Research analyst Rudy Li has maintained their bullish stance on CMPS stock, giving a Buy rating today. Rudy Li has given his Buy rating due t...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/analyst-reaffirms-buy-on-cmps-viewing-post-data-pullback-as-entry-opportunity-ahead-of-1h27-launch-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/analyst-reaffirms-buy-on-cmps-viewing-post-data-pullback-as-entry-opportunity-ahead-of-1h27-launch-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4212","PSIL","POST","BK4139","CMPS"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":200,"code":"91000000","status":"200"}]}}